MediPharm Labs Corp.
MEDIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $24,232 | $23,377 | $18,258 | $46,121 |
| - Cash | $11,690 | $17,981 | $24,145 | $34,110 |
| + Debt | $388 | $2,295 | $632 | $216 |
| Enterprise Value | $12,930 | $7,691 | -$5,255 | $12,227 |
| Revenue | $41,961 | $33,062 | $22,117 | $21,711 |
| % Growth | 26.9% | 49.5% | 1.9% | – |
| Gross Profit | $12,805 | $5,855 | -$1,914 | -$15,246 |
| % Margin | 30.5% | 17.7% | -8.7% | -70.2% |
| EBITDA | -$7,518 | -$10,478 | -$25,440 | -$38,549 |
| % Margin | -17.9% | -31.7% | -115% | -177.6% |
| Net Income | -$10,694 | -$13,083 | -$29,983 | -$54,801 |
| % Margin | -25.5% | -39.6% | -135.6% | -252.4% |
| EPS Diluted | -0.026 | -0.036 | -0.11 | -0.22 |
| % Growth | 27.2% | 67.3% | 50% | – |
| Operating Cash Flow | -$4,861 | -$11,763 | -$16,069 | -$13,213 |
| Capital Expenditures | -$154 | -$471 | -$863 | -$783 |
| Free Cash Flow | -$5,015 | -$12,234 | -$16,932 | -$13,996 |